PSMB8 and colorectal cancer: Here, we specifically addressed the effect of two multikinase inhibitors (MKIs) on the proteasome activity, expression and intracellular localization of non-constitutive proteasomes using two genetically modified colorectal cancer cell lines, engineered to express fluorescently labeled non-constitutive proteasome subunit β5i.